Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Vesical Imaging-Reporting And Data System and Apparent Diffusion Coefficient Values (the VI-RADS/ADC) Accurately Predict Non-Muscle Invasive Bladder Cancer

NCT04167631 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT04167631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04167631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Vesical Imaging-Reporting And Data System and Apparent Diffusion Coefficient Values (the VI-RADS/ADC) Accurately Predict Non-Muscle Invasive Bladder Cancer
Lead sponsor
Mansoura University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 1, 2019
Completion date
December 31, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, bladder cancer stage, bladder disease, bladder neoplasm, bladder urothelial carcinoma, diagnoses disease, mri contrast media adverse reaction